XML 40 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders’ Equity (Tables)
 3 Months Ended
Mar. 31, 2026
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Activity

A summary of restricted stock activity during the period January 1, 2025 to March 31, 2026 is as follows:

 

   Total
restricted
shares		   Weighted
average
fair market
value per
share		   Total
unvested
restricted
shares		  Weighted
average
fair market
value per
share		   Total
vested
restricted
shares		   Weighted
average
fair market
value per share		 
Outstanding January 1, 2025   783,167   $1.5000    
   -
    $
-
    783,167   $1.50 
Granted and issued   67,500,000    0.0037    
-
     
-
    67,500,000    0.0037 
Forfeited/Cancelled   
-
    
-
    
-
     
-
    
-
    
-
 
Vested   
-
    
-
    
-
     
-
    
-
    
-
 
Outstanding December 31, 2025   68,283,167   $0.0207    
-
    $    -    68,283,167   $0.0207 
Granted and issued   50,000,000    0.0126    
-
     
-
    50,000,000    0.0126 
Forfeited/Cancelled   
-
    
-
    
-
     
-
    
-
    
-
 
Vested   
-
    
-
    
-
     
-
    
-
    
-
 
Outstanding March 31, 2026   118,283,167   $0.0173    
-
    $    -    118,283,167   $0.0173 
Schedule of Expense and Settled Outstanding Liabilities

The restricted stock granted, issued and exercisable at March 31, 2026 is as follows:

 

    Restricted Stock
Granted and Vested		 
Grant date Price   Number Granted   Weighted Average
Fair Value per Share		 
$0.0037    67,500,000    0.0037 
$0.0126    50,000,000    0.0126 
$1.4700    683,167   $1.4700 
$1.5000    33,333    1.5000 
$1.6500    66,667    1.6500 
      118,283,167   $0.0173 
Schedule of Expense and Settled Outstanding Liabilities

The Company has recorded an expense and settled outstanding liabilities as follows:

 

Grant date 

Number of
shares
granted

  

Vesting
terms

  

Grant
date
fair value

  

Expensed
during
the
period

  

Liability
settled

 
                     
February 3, 2026   50,000,000    Immediate   $630,000   $553,000   $77,000 
Schedule of Fair Value of the Warrants Granted and Issued

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Three months  
ended
March 31,
2026		   Year ended
December 31,
2025		 
         
Exercise price  $0.01 to 0.02   $0.0005 to 0.084 
Risk free interest rate   3.79 to 3.80%   3.77 to 4.46%
Expected life of derivative liability   3 to 5 years    1 to 5 years 
Expected volatility of underlying stock   197.25 to 211.22%   183.1 to 352.45%
Expected dividend rate   0%   0%
Schedule of Warrant Activity

A summary of warrant activity during the period January 1, 2025 to March 31, 2026 is as follows:

 

   Shares
Underlying
Warrants		   Exercise
price per
share		   Weighted
average
exercise
price		 
Outstanding January 1, 2025   22,011,614   $0.084 – 5.625   $0.319900 
Granted   55,204,761    0.005 to 0.084    0.00474 
Increase in warrants issued due to anti-dilution price protection   2,157,367,790    0.0005    0.00050 
Forfeited   (1,853,425,066)   0.0005 to $4.50    0.00149 
Exercised   (531,165)   0.0005 to 1.035    0.97430 
Outstanding December 31, 2025   380,627,934   $0.0005 – 5.625   $0.01052 
Granted   17,250,000    0.01 to 0.02    0.01072 
Forfeited   (552,438)   0.0005 to 5.625    2.22652 
Exercised   
-
    
-
    
-
 
Outstanding March 31, 2026   397,325,496   $0.0005 – 1.5000   $0.00745 
Schedule of Warrants Outstanding and Exercisable

The warrants outstanding and exercisable at March 31, 2026 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise Price*   Number
Outstanding		   Weighted
Average
Remaining
Contractual
life in years		   Weighted
Average
Exercise
Price		   Number
Exercisable		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contractual
life in years		 
$0.000500    370,285,776    3.01         370,285,776         3.01 
$0.010000    18,550,000    4.90         18,550,000         4.90 
$0.020000    1,250,000    2.97         1,250,000         2.97 
$0.345000    6,939,718    2.45         6,939,718         2.45 
$0.450000    266,668    2.23         266,668         2.23 
$1.500000    33,334    2.37         33,334         2.37 
      397,325,496    3.08   $0.00745    397,325,496   $0.00745    3.08 
Schedule of Option Activity

A summary of option activity during the period January 1, 2025 to March 31, 2026 is as follows:

 

   Shares
Underlying
options		   Exercise
price per
share		   Weighted
average
exercise
price		 
Outstanding January 1, 2025   1,513,335   $1.20 to 12.00   $4.47 
Granted   600,000    0.09    0.09 
Forfeited/Cancelled   (333,334)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2025   1,780,001   $0.09 to 12.00   $2.989 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding March 31, 2026   1,780,001   $0.09 to 12.00   $2.989 
Schedule of Options Outstanding and Exercisable

The options outstanding and exercisable at March 31, 2026 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise Price*   Number
Outstanding		   Weighted
Average
Remaining
Contractual
life in years		   Weighted
Average
Exercise
Price		   Number
Exercisable		   Weighted
Average
Exercise
Price		   Weighted
Average
Remaining
Contractual
life in years		 
$0.09    600,000    8.78         425,000         8.78 
$1.20    13,334    6.46         13,334         6.46 
$4.50    1,166,667    5.77         1,166,667         5.77 
      1,780,001    6.79   $2.989    1,605,001   $3.305    6.79